PHARMAGEDDON
ROCKET FUEL FOR LIFE SCIENCES DISRUPTORS
- A NEW EVENT FOR PHARMA
- 18-19 OCTOBER, 2023 · BARCELONA
- L'ESTACIó ESPAI GASTRONòMIC
ROCKET FUEL FOR LIFE SCIENCES DISRUPTORS
Sometimes, you have to break things down before you can build them up again.
Pharmageddon is a brand new event, designed to dismantle our assumptions about the status quo and recreate a better industry for patients, HCPs and ourselves.
This is not a conference. Instead of testing your stamina by struggling through dozens of vendor presentations, you’ll work in cross-functional teams to devise solutions that are bigger and better than you ever got to work on before now. But beware! This event is only for those prepared to use their imagination, to experiment, and push outside their comfort zone.
Over two days, you will experience the Impatient innovation process. Part speculative design, part design sprint, part change management, you will learn a methodology that you’ll be able to apply back at home to deliver more ambitious goals. Built for life sciences leaders that want to ensure that commercial and medical teams become innovators rather than simply communicators, you’ll be surprised at how you’re able to create novel yet pragmatic solutions. To learn more, click here.
Content must be compelling. Devise new customer platforms that HCPs get passionate about - and graduate from omnichannel to omnipresent.
Devise new joint ventures with stakeholders, patients and health systems that volunteer data, uncover insights and create win-win-wins.
Digital transformation is dead. Design new organisational structures that break commercial-medical silos, boost equity and enable rapid iteration with patients.
An experience, not a conference
Combining the most useful elements of human-centred design, evolutionary biology, concept ideation and agile methodology, this event will guide small project teams, composed of creative thinkers, through exercises and scenarios designed to tackle our biggest challenges. By the end of the experience we’ll have co-created multiple innovative, patient-focussed solutions.
— PAUL SIMMS, HOST
Put that many smart minds in one room, and it’d be crazy just to sit passively next to them. By designing challenging exercises we will ensure everyone hits their full potential.
We’ve searched for Barcelona’s most other-wordly venue, and we believe we’ve found it. Join us where it’ll be impossible to stay in the world you’re used to.
We know the only constant is change, and uncertainty is here to stay. Learn innovation management techniques that are suited to today’s environment and the needs of HCPs and patients.
Explore more ambitious goals and drive change through understanding emerging technologies, human and sociological trends
Empower teams to think beyond communication and into true innovation, resulting in practical solutions to complex problems.
Speculative tools allow you to explore potential future scenarios and influences. Identify new opportunities and stay ahead of the curve.
Gain deeper understanding of the needs of customers and stakeholders to develop solutions in more impactful ways.
Anticipate changes, quickly prototype ideas, validate, move faster and make decisions based on data rather than assumptions. Much more than agility!
Experience the methodology for yourself and see how the mindset shift enables different possibilities to come into focus, empowering teams.
Conferences typically feature keynote CEOs who don’t say more than what’s written on last week’s press release. We host a much more interesting crowd. The crowd you really want to meet. Look who has already registered:
Paul Simms, Chief Executive, Impatient Health
Paul recently established Impatient Health, a cross between a think-tank, a consultancy and a design studio for pharma, with more than 25 clients looking to redesign how value can be created in life sciences. He is sometimes known as the ‘pharma provocateur’ for his role in provoking and rethinking business models. His industry journey started in June 2003 with ‘eyeforpharma’, an organisation which he quickly grew into the pharmaceutical industry’s most influential event organiser, acquired by Reuters in 2019. CEOs and disruptors regularly featured on Paul’s stages, especially at flagship events in Barcelona, Philadelphia, Tokyo and Sydney. Paul also devised and managed the only pharmaceutical award ceremony to focus on patient and healthcare value.
Paul has recently presented at companies including AstraZeneca, Roche, Merck, Leo, AbbVie, Abbott, Novo Nordisk, Sanofi and Takeda. He chairs approximately 20 webinars per year, each with audiences of between 500 and 2500. He has perhaps the largest contact book in the pharmaceutical industry, covering all major companies at C-level. Paul also co-founded The Aurora Project, a non-profit designed to make patient centricity more commonplace within pharmaceuticals. He is an Advisory Board member at Hu-manity.co and a Trustee at patient charity Fibro Flutters.
Erasmus Holm, Director, General Medicine & Commercial Operations, Netherlands, MSD
Erasmus is a Global Sales & Marketing Senior Executive with 15+ years global experience in management, marketing, business development, change management, innovation and sales management in the High-tech, Consulting and Pharmaceutical industry.
He has a passion for - and fundamental faith in - that real creativity, vision, passion and data can solve the toughest business problems.
His specialties are within: Pharma/IT/Consulting/Software Marketing, General Management, Marketing Management, Strategy & Business Development, Branding & Identity, Marketing Efficiency & Automation, PR, Product Marketing, Partner Marketing, Visual Communication, Online Advertising, Digital Marketing, Event Management, Go-to-Market Strategy, Sales Management, Direct Sales, Channel Development, Internationalization, Emerging Market Development, Strategy, Planning, Operations, People Management and more.
Irina Osovskaya, Global Digital Strategy Director, AstraZeneca
Irina is a dynamic and inspirational leader with significant experience gained with major Healthcare and IT organisations globally. Proven experience in Digital strategy development, disruptive innovation and implementation of new working practices and new technologies as part of continuous process review. Early adopter with extensive experience of early technology pilots from conception, engagement with marketing and medical teams through to scalable solutions delivery.
Highly experienced opinion leader in digital marketing, regular keynote speaker at international pharmaceutical marketing conferences on Closed Loop Marketing, eDetailing and Social Media. Broad network across J & J (cross-sector and internationally) and externally. Member of Digital Awards judging panel for UK’s Pharmaceutical Marketing Society since 2009 and Communique Digital awards since 2014; selected as a runner-up in PM Society Digital Pioneer 2009 awards.
Chartered Marketer and a Member of the Chartered of Institute of Marketing (Post-graduate diploma in Marketing). Received a Master of Science degree in Information Systems and Computing from Brunel University. APMG-certified Change Management Practitioner. Currently working on a PhD at UCL with focus on impact of PCHRs combined with other digital health interventions on patient outcomes.
Helena Bargiel, Insight2Impact Operational Excellence Lead Europe, UCB
Helena has increased sales 53% to 250% and secured approval by changing employees’ mindsets. She has also rolled out sustainable business solutions in 27 countries, led 3 regions and +40 markets, and repeatedly challenged the ‘not invented here’ mindset to secure a top spot 75% faster and exceed sales 98% (stakeholder management was key).
Sustainability is close to her heart. She has built sustainability in international businesses, teams, services and internal work in all my positions.
I have built a reputation for taking innovative projects and teams from concept development on a global and regional level to sustainable business in local markets. I still get asked by numerous former employees to as act mentor/sounding board.
Early in my career, I reversed a negative trend by co-devising/launching a pioneering website and co-designing a nationwide program.
TODAY I have:
SPEAKER & PANELLIST ASSIGNMENTS:
Tiana Homsani, Global Head of Marketing Excellence, Abbott
Global Head Innovation & Digital Commercial Transformation...
As an Industrial and Mechanical Engineer with 20+ years of global executive experience, I am first and foremost a balanced person...from myself, to my family and the office.
Where Am I Now:
Currently I report to the CMO in a Pharma company, with the dotted line reporting to the Divisional Head of Digital and Strategy.
Who I Am at Work:
An authentic commercial execution leader, focusing on maximizing my impact and creating an environment that people want to be a part of.
I achieve results with my business unit by removing obstacles and empowering each individual, all while striving to be a magnet of abundance, energy and love.
I combine a Pharma and automotive background, which gives me the ability to navigate the complexity of those environments.
The Results I Achieve:
I led a digital transformation and innovation initiative that saved $18M in 12-months, across 120 countries including US, Europe, China, Japan and Latin America.
Sales Leadership in Pharmaceuticals:
I've led cross-functional teams of 100+ and controlled P&L for $800M. In Pharma, I've managed a portfolio of 12BUSD in sales.
My Mottos:
"Every day is a new beginning, so make it better than yesterday."
"In the moments of decision, my destiny is shaped."
Philippe Barillon, Global Integrated Insights Lead, Cardiovascular TA, Novartis
Philippe is a digital-savvy biopharmaceutical leader with a track record of improving insights discovery and decision-making. Demonstrated leadership in large global organizations leading change and establishing innovative and efficient business processes and mindset.
Patrick Markt, Head of Digital Excellence Europe, Daiichi Sankyo
Patrick is a PhD and diploma degree educated and internationally experienced individual having worked for EY life science division (formerly Novumed) and the pharma companies Celgene and Daiichi Sankyo. He has profound experience in strategic and commercial excellence, acquired through diverse responsibilities in affiliate and HQ roles. His focus has been on European strategic planning, evaluation of commercial and sales strategy, sales force excellence, support of brand planning and product launches including digitization strategy and implementation. He has vast experience in change management, PMO and held P&L responsibility across several functions. Patrick is a trusted partner of the local and European executive board, has a flexible mind, strong analytical and communication skills. He enhances business value by proactively driving key projects to success through reconciliation to business priorities and encouraging cross-functional collaborations.
Patrick has been responsible to coordinate Brexit preparations as well as steering and implementing pan-European projects like building a digital lab from scratch. His ability to quickly incorporate into new business areas and to work at and with all levels within an organization helps him to manage complex matrix projects. Patrick’s ability to manage high-pressure situations calmly and positively qualified him as a valued European leader.
Haider Alleg, Global Head of Digital Excellence, Ferring
Haider is an entrepreneur, blending innovation, commercial and marketing leadership into brands. He is specialised on business transformation and product launches within regulated industries such as pharma.
Developing a natural obsession for creating new customer experiences, Haider disrupts the way global organisations adopt new marketing and technology trends. He is inspired by Japanese methodologies (Kaizen and Lean 6 Sigma) and adapts them to commercial operations to scale their business models globally.
Entrepreneur, he founded his first company at 16 in the East of France, specialised in political campaigns and social media.
In 2013 he founded one of the fastest-growing consulting and venture firms in Switzerland, supporting companies like PregLem SA, sold to Gedeon Richter for 500M€.
In 2015, he founded the Swiss hub of the French Tech initiative, created by the French President Emmanuel Macron.
Feel free to follow him on his Twitter account (@Haider_Alleg).
Emma Booth, Executive Director, Ex-US Medical Capabilities, Amgen
Emma is professional, trustworthy and a balanced strategic partner. She is solution-focused and comfortable working in a constantly changing environment. People-focused from both team development and skills building perspective as well as organizational design and implementation. Experienced in systems design, technological solutions and process development. Collaborative cross-functional partner with commercial, value and access, legal, compliance, HR, IS. Accomplished in managing and connecting multiple global and regional initiatives to ensure efficient and optimal roll out and acceptance while minimizing disruption. Broad experience in brand planning, medical affairs activities and tactics and development of commercial materials.
Florent Edouard, SVP, Global Head of Commercial Excellence, Grünenthal
Florent is a Business and team builder for companies who value patients, customer experience, innovation and entrepreneurship. At Grunenthal, he is:
Mostafa Taha, Chief Transformation Lead - Global Business Innovation, Merck
Pharma leader with over 15 years in sales, Marketing, Project Management & Commercial Excellence experience on local, regional and global scopes, proven track record of developing and implementing business strategies.
Cyril Mandry, Senior Director Global Digital Marketing & Omnichannel Customer Engagement - Pharmaceuticals, Merck
Cyril is a Senior marketing director, global digital lead and business unit lead with 20+ years' experience in blue chip companies (Unilever, MSD, Coca-Cola, Pernod Ricard) at the international and local levels
Heather Moses, Head of Europe & Canada Medical Affairs, AstraZeneca
Heather is a dynamic innovative leader, with a patient-focussed, insights-led, customer-centric approach. She has over 15 years of experience in pharma across medical, commercial, and access projects. Her experiences have led to a deep understanding of product strategy and customer focus in an evolving competitive environment.
Davidek Herron, Global Head of Digital, Roche
Davidek's passion is to get medicines to patients in need. His focus is on healthcare technology, specializing in digital marketing, sales, customer experience, e-commerce, commercial excellence and brand launch. He enjoys building high-performing global teams and creating rich customer experiences for large and small brands. He notably created Teva’s Internal Sales team that was sold with Paragard for $1.1 Billion and is currently working in AI and machine learning to create the next go to market models that shapes healthcare post Covid-19.
Aleja Betancourt, Leading transformational cross-functional initiatives, Novo Nordisk
Responsible for leading transformational cross-functional initiatives within Marketing Operations, mainly focusing on scaling and expanding scope of the two existing units Content Hub and MCE Execution Service. System ownership of global platforms, ensuring consistent operations, compliance and maintenance of several business critical commercial platforms, incl. global websites (Extweb) and global promotional review platform (Veeva Promomats)
Christoph Pontasch, Information technology executive, Boehringer Ingelheim
Information technology executive with extensive experience in building and leading diverse information management and software engineering teams in the healthcare industry. Experienced global leader with proven ability to identify strategic initiatives, align stakeholders, and deliver elegant and workable solutions on time and on budget. Accomplished software architect and information integrator, creator of numerous highly successful information management systems. Advocate of empowered leadership with a passion for building organizational frameworks that promote collaboration, engagement and connectivity across functional, regional, and cultural boundaries.
Rasmus Just, Business development executive, Inventor, Entrepreneur, Strategist and Leader, ALK Abello
Business development executive, Inventor, Entrepreneur, Strategist and Leader with track record of high performance. Motivated by science, high ambitions and team performance to achieve outstanding results.
Background as PhD in molecular pharmacology with expert skills in receptor mechanics, cellular biology, health & pathology, metabolic disease understanding and deeply passionate about setting the bar extremely high in Innovation and moving boundaries by process enhanced boldness, teaming and grit.
MBA from AVT business school in Copenhagen. Strong believer in collaboration and bold ambitions to develop medicines and health tech with the potential to revolutionize treatment, cure and patients lives.
Extensive hands-on laboratory experience and broad understanding of the whole drug discovery value chain and significant experience in collaborative work within Industry and between Industry and academia.
Paul Simms, Chief Executive, Impatient Health
Paul recently established Impatient Health, a cross between a think-tank, a consultancy and a design studio for pharma, with more than 25 clients looking to redesign how value can be created in life sciences. He is sometimes known as the ‘pharma provocateur’ for his role in provoking and rethinking business models. His industry journey started in June 2003 with ‘eyeforpharma’, an organisation which he quickly grew into the pharmaceutical industry’s most influential event organiser, acquired by Reuters in 2019. CEOs and disruptors regularly featured on Paul’s stages, especially at flagship events in Barcelona, Philadelphia, Tokyo and Sydney. Paul also devised and managed the only pharmaceutical award ceremony to focus on patient and healthcare value.
Paul has recently presented at companies including AstraZeneca, Roche, Merck, Leo, AbbVie, Abbott, Novo Nordisk, Sanofi and Takeda. He chairs approximately 20 webinars per year, each with audiences of between 500 and 2500. He has perhaps the largest contact book in the pharmaceutical industry, covering all major companies at C-level. Paul also co-founded The Aurora Project, a non-profit designed to make patient centricity more commonplace within pharmaceuticals. He is an Advisory Board member at Hu-manity.co and a Trustee at patient charity Fibro Flutters.
Av. del Marquès de l'Argentera, 6, 8, 08002 Barcelona, Spain
Commercial leaders must find new engagement paradigms for HCPs whilst empowering a more entrepreneurial workforce. In many cases headcount will be cut in 2023 and we will need much more from every retained role.
Medical affairs isn’t just going from support to strategic, it’s the nexus of data and decision-making. Medical leaders must set the scientific narrative and become the primary relationship-builders without compromising authenticity.
Marketing executives should consider omnichannel as the starting point for new narratives, inspiring both HCPs and patients to take responsibility and achieve a new standard of care.
Digital Health pioneers are the key to holistic healthcare in the modern age. But bringing impactful projects to life has more to do with strategy than sizzle if we are to really influence patient outcomes.
“Impatient Health hosted a mind-opening experience… my assumptions on strategy were challenged, and changed… and I met a fantastic group of like-minded people determined to make a change in this industry.”
Emma Booth
Executive Director Global Business Process and
Insights Lead, R&D Strategy and Operations
“Impatient Health’s agile design thinking approach, combined with deep industry knowledge and expertise, is highly valued by our company and we strongly recommend choosing them as a partner to bring your vision to life.”
Silviya Aleksandrova
CredoWeb
“We chose Impatient Health for two simple reasons. First, Paul and his team have relationships with executive-level thought leaders across the industry from emerging startups through to the global top ten pharmaceutical companies. And second, their desire to push the envelope and challenge the status quo is tightly aligned with our strategy and vision. Our initial project did not disappoint on either metric and we look forward to our next engagement.”
Philip Mccrea
Red Nucleus
In order to keep the ratio of pharma attendees high, there are no standard tickets available for solution providers.
However, if you are an industry pioneer, we have a number of opportunities for companies looking for presence and strong relationships with early adopters.
Please contact Richard or Alex on [email protected] to find out more!
Thanks for being keen to join us in Barcelona.
Our intention is to have one non-affiliated ‘patient’ for each team taking part. If you are interested in being one of these, please write to Elena on [email protected].
We also have a limited number of spaces for HCPs, media and others. Please write to Paul on [email protected] if eager to take part.
